September 2015

The Dietary Guidelines Advisory Committee said the way meat is raised is bad for the environment. A project from the Netherlands offers a high-tech, if expensive, solution.

The Dietary Guidelines Advisory Committee recommendation to limit added sugar comes as little surprise to the food industry, which has quietly been curbing the amount of sugar in products aimed at children in response to concerns about obesity.

Fingernail tests could offer a solution to diabetes testing in the developing world, and a faster test for gestational diabetes could diagnose this condition earlier in pregnancy.

Younger patients and those newly diagnosed were more likely to not receive eye exams than older persons with diabetes.

Research primarily at Virginia Commonwealth University focuses on a key regulator of metabolic diseases as well as cancer.

The matchstick-like delivery system has been seen as game-changer in overcoming poor adherence. Filing for FDA approval is anticipated in early 2016.

The study showed an average weight loss of 6%, and weight loss of 10% for a quarter of the patients. Average BMI was 37.

The decision by Cleveland Clinic's Steven Nissen, MD, to issue his own press release last spring after the cardiovascular outcomes trial was halted for Contrave turned plenty of heads in the pharmaceutical community. But Nissen and others involved in the saga see what happened with Orexigen as a one-time incident, not a flaw with the process for evaluating the safety of diabetes and obesity therapies.

Many hoped the 2013 declaration by the American Medical Association that obesity is a disease would open the door to improved coverage for pharmcotherapy. That did not happen right away, but signs of change are emerging.

A 5-year study reveals that the properly constructed diet, along with exercise aimed at muscle maintenance, can achieve long-term weight loss results.

When prices of the first 2 entrants of this new class of cholesterol-lowering drugs came in well above expectations, leading PBMs announced plans to limit who could gain access and sent a clear message to the drug makers: get ready to negotiate.

Evidence-Based Diabetes Management gained exclusive access to the Comprehensive Weight Management Program for a view of what "behavioral change" really means for patients overcoming obesity and for the clinicians managing their care.